Optoseeker Biotechnology (Shenzhen) Co., Ltd. was founded in 2023 by professors from Beijing Institute of Technology, Southern University of Science and Technology, and Jinan University, alongside several returnee Ph.D. scholars. Guided by the philosophy of "empowering life through technology," the company accelerates the translation of scientific achievements in biomedicine and cell and gene therapy, pioneering a new era of health innovation. Focusing on the fundamental value chain in life sciences, Optoseeker Biotechnology develops advanced life science instrument platforms dedicated to resolving bottleneck issues in related technological fields. Its product portfolio encompasses biochips, digital microfluidics, and live cell screening platforms, primarily serving the biopharmaceutical (AI), precision medicine, and synthetic biology sectors.